Abstract
Twenty-five 3-substituted isocoumarins were synthesized using cutting edge microwave-assisted technology in high yields. The syntheses of different isocoumarins were carried out in a single step by the direct condensation of homophthalic acid with aryol and acyl chlorides under the solvent-free conditions without any solid support. The structures of all the synthesized compounds were characterized using different spectroscopic techniques including UV, IR, 1HNMR and EIMS and purity was confirmed by CHN analysis. All the synthesized compounds were tested for in vitro leishmanicidal activity. Compounds 3a, 3b, 3g, 3l, 3m, 3r, 3t, 3w, 3x, and 3y displayed potential in vitro leishmanicidal activity with IC50 values in the range of 0.56-84.38 μg/ml, whereas standard inhibitors amphotericine B have IC50 = 0.24 μg/ml. The compounds 3b, 3g, 3m, 3t, 3w, 3x, and 3y having IC50 values 27.86, 28.88, 36.49, 34.37, 28.68, 0.89 and 0.56 μg/ml, respectively, were most active among the present series while remaining others were found less active. The compound 3x and 3y can act as potential lead molecules for further development of isocoumarin-based new drugs for the treatment of leishmaniasis.
Keywords: 3-Substituted isocoumarins, microwave-assisted synthesis, leishmanicidal activity
Medicinal Chemistry
Title: In Vitro Leishmanicidal Activity of 3-substituted Isocoumarins: Synthesis and Structure activity Relationship
Volume: 4 Issue: 2
Author(s): Khalid Mohammed Khan, Sumbul Ahmed, Zulfiqar Ali Khan, Zia-Ullah, Mubeen Rani, Muhammad Iqbal Choudhary and Shahnaz Perveen
Affiliation:
Keywords: 3-Substituted isocoumarins, microwave-assisted synthesis, leishmanicidal activity
Abstract: Twenty-five 3-substituted isocoumarins were synthesized using cutting edge microwave-assisted technology in high yields. The syntheses of different isocoumarins were carried out in a single step by the direct condensation of homophthalic acid with aryol and acyl chlorides under the solvent-free conditions without any solid support. The structures of all the synthesized compounds were characterized using different spectroscopic techniques including UV, IR, 1HNMR and EIMS and purity was confirmed by CHN analysis. All the synthesized compounds were tested for in vitro leishmanicidal activity. Compounds 3a, 3b, 3g, 3l, 3m, 3r, 3t, 3w, 3x, and 3y displayed potential in vitro leishmanicidal activity with IC50 values in the range of 0.56-84.38 μg/ml, whereas standard inhibitors amphotericine B have IC50 = 0.24 μg/ml. The compounds 3b, 3g, 3m, 3t, 3w, 3x, and 3y having IC50 values 27.86, 28.88, 36.49, 34.37, 28.68, 0.89 and 0.56 μg/ml, respectively, were most active among the present series while remaining others were found less active. The compound 3x and 3y can act as potential lead molecules for further development of isocoumarin-based new drugs for the treatment of leishmaniasis.
Export Options
About this article
Cite this article as:
Khan Mohammed Khalid, Ahmed Sumbul, Khan Ali Zulfiqar, Zia-Ullah , Rani Mubeen, Choudhary Iqbal Muhammad and Perveen Shahnaz, In Vitro Leishmanicidal Activity of 3-substituted Isocoumarins: Synthesis and Structure activity Relationship, Medicinal Chemistry 2008; 4 (2) . https://dx.doi.org/10.2174/157340608783789130
DOI https://dx.doi.org/10.2174/157340608783789130 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Presentations and Diagnosis of Brucellosis
Recent Patents on Anti-Infective Drug Discovery Reactive Oxygen Species, Vascular Disease and Cardiovascular Surgery
Current Vascular Pharmacology Recent Patents and Patent Applications Relating to mTOR Pathway
Recent Patents on DNA & Gene Sequences Dissections of the Thoracic Aorta and Evolving Endovascular Strategies
Current Hypertension Reviews Oral Angiotensin-(1-7) Peptide Modulates Intestinal Microbiota Improving Metabolic Profile in Obese Mice
Protein & Peptide Letters Lipid Management and Peripheral Arterial Disease
Current Drug Targets Exploration of the Medicinal Peptide Space
Protein & Peptide Letters Treatment Strategy Issues for Chronic HIV-1 Infection in Adults: The Dilemma of Life-long Antiretroviral Treatment
Current Medicinal Chemistry - Anti-Infective Agents High Sensitivity C-Reactive Protein (hsCRP): A New Biochemical Marker of Atherosclerotic Vascular Disease
Current Cardiology Reviews Desensitization for Drug Hypersensitivity to Chemotherapy and Monoclonal Antibodies
Current Pharmaceutical Design Healthcare Management During A Pandemic: The Other Side of the Coin for the Treatment of COVID-19 Infection
Endocrine, Metabolic & Immune Disorders - Drug Targets Allergen-Induced Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Antimicrobial Drug Interactions in the Critically Ill Patients
Current Clinical Pharmacology Endothelin Receptor Antagonists: A New Therapeutic Option for Improving the Outcome after Solid Organ Transplantation?
Current Vascular Pharmacology Cocaine and Acute Vascular Diseases
Current Drug Abuse Reviews Intracellular and Extracellular miRNAs in Regulation of Angiogenesis Signaling
Current Angiogenesis (Discontinued) Recent Advancements in Pharmacological Stent Therapy Using Polymeric Materials: Opportunities and Challenges
Current Drug Delivery The Electrocardiographic Manifestations of Arrhythmogenic Right Ventricular Dysplasia
Current Cardiology Reviews Contribution of Catecholamine Reactive Intermediates and Oxidative Stress to the Pathologic Features of Heart Diseases
Current Medicinal Chemistry Immune System Modulation by Thyroid Axis Includes Direct Genomic and Nongenomic Actions of Thyroid Hormones on Immune Cells
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)